UnitedHealth Group Incorporated $UNH Shares Sold by Ameriprise Financial Inc.

Key Points

• Ameriprise Financial Inc. has reduced its stake in UnitedHealth Group by 16.7%, now holding approximately 3,897,572 shares valued at over $2 billion.
• GAMMA Investing LLC significantly increased its position in UnitedHealth Group, acquiring over 8.28 million shares which marks a 56,142.1% increase in its holdings.
• UnitedHealth Group's most recent earnings report showed a miss on earnings per share at $4.08 compared to the expected $4.45, despite reporting a revenue increase of 12.9% year-over-year.

Ameriprise Financial Inc. reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,897,572 shares of the healthcare conglomerate's stock after selling 781,694 shares during the period. UnitedHealth Group comprises approximately 0.6% of Ameriprise Financial Inc.'s holdings, making the stock its 26th largest holding. Ameriprise Financial Inc. owned about 0.43% of UnitedHealth Group worth $2,041,489,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in UNH. GAMMA Investing LLC grew its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares in the last quarter. Nuveen LLC bought a new position in shares of UnitedHealth Group in the first quarter worth $3,846,764,000. Vanguard Group Inc. boosted its stake in UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after buying an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after buying an additional 2,486,839 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after buying an additional 2,301,010 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the transaction, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. The trade was a 5.36% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 0.28% of the company's stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the company. HSBC reaffirmed a "reduce" rating and set a $270.00 target price (down from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Piper Sandler reduced their target price on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. Royal Bank Of Canada reduced their target price on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a report on Wednesday, July 30th. Wolfe Research reduced their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research note on Tuesday, May 20th. Finally, Wall Street Zen downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. Fifteen research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and a consensus target price of $365.38.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $299.8310 on Thursday. The business's 50 day moving average price is $288.81 and its two-hundred day moving average price is $392.90. The company has a market cap of $271.55 billion, a PE ratio of 12.99, a price-to-earnings-growth ratio of 1.96 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the company earned $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.9%. UnitedHealth Group's payout ratio is 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.